Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-10

Clinical Trial Update: VIA Disc NP Registry

View source ↗

Summary

The VIA Disc NP Registry trial by VIVEX Biologics has been terminated, ending enrollment and study activities. The registry studied discogenic back pain and rel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VIA Disc NP

Snippet

Sponsor: VIVEX Biologics, Inc. | Conditions: Discogenic Pain, Back Pain | Status: TERMINATED